Chronic Venous Occlusions Treatment Market Size

Chronic Venous Occlusions Treatment Market Size

Chronic Venous Occlusions Treatment Market was valued at over USD 5.5 billion in 2021 and is projected to witness significant growth at a 5.5% CAGR through 2030 primarily driven by the rising awareness about available treatment options for chronic venous occlusion.

To get key market trends

  Download Free Sample

Increasing awareness about the treatments accessible to patients as well as the growing prevalence of chronic illnesses associated with varicose veins are foreseen to fuel market expansion. A report by BMC Nursing Journal stated that the occurrences of varicose veins among adults were between 20% and 60% worldwide and is speculated to continue to grow steadily in the coming years. Additionally, several nations and industry participants are working on raising awareness of the various treatment and diagnoses for chronic illnesses like varicose veins and their related symptoms, thereby improving business prospects.

Stringent regulatory framework may impede market statistics

Rules governing chronic venous occlusions treatment have slowed the market's progress. The U.S. FDA (Food and Drug Administration) regulates the operating procedures as well as the drugs used in the treatment. For instance, phlebotonics, which are essential medications for the diagnosis of chronic venous insufficiency and help minimize ankle swelling and accelerate the healing of leg ulcers, have not yet received government approval in the U.S. However, surging awareness and favorable government programs for lower extremity disorders are likely to sustain market development.